Unmet weight loss targets in real-world clinical practice: weight management and perceptions in China

被引:1
|
作者
Lin, Ziwei [1 ]
Si, Si [1 ]
Liu, Jia [2 ]
Zhu, Hao [1 ]
Xu, Jiawei [1 ]
Artime, Esther [3 ]
Khare, Swarna [4 ]
Higgins, Victoria [5 ]
Leith, Andrea [5 ]
Qu, Shen [2 ,6 ]
机构
[1] Eli Lilly & Co, Suzhou, Peoples R China
[2] Tongji Univ, Shanghai Peoples Hosp 10, Endocrinol & Metab Ctr, Sch Med, Shanghai, Peoples R China
[3] Eli Lilly & Co, Alcobendas, Spain
[4] Eli Lilly & Co, Bracknell, England
[5] Adelphi Real World, Bollington, England
[6] SinoUnited Hlth, Endocrinol Metab & Thyroid Ctr, Shanghai, Peoples R China
来源
关键词
China; dietary intervention; obesity therapy; real-world evidence; weight control; OBESITY; OVERWEIGHT;
D O I
10.3389/fendo.2024.1470394
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To describe weight management and perceptions in China.Materials and methods Data were from the Adelphi Real World Obesity Disease Specific Programme (TM), a cross-sectional survey between April and July 2022 of physicians managing people with obesity or overweight (PwO) and PwO in real-world clinical practice in China. At data collection, eligible PwO were aged >= 18 years, under weight management and/or had a body mass index (BMI) >= 28 kg/m2.Results In total, 100 physicians and 801 PwO were enrolled. More than two thirds of PwO (70.7%; 531/751) were not diagnosed with obesity until a BMI >= 30 kg/m2. Most PwO (78%; 625/801) were on treatment for at least one obesity-related complication (ORC). Physicians commonly initiated weight loss discussions with PwO who already had an ORC (48.0%; 48/100). According to physicians and PwO, the mean target BMI was set at 25.8 kg/m2 and 24.3 kg/m2, and the mean target percentage weight loss was 19.6% and 23.7%, respectively. Over a median 6.4 months of weight management, the mean percentage weight loss was 4.1%. Few PwO achieved the weight loss target set by their physician (9.9%; 69/695) or themselves (2.0%; 14/696). Most physicians and PwO were unsatisfied with the current weight loss (92.3% [739/801] and 82.0% [650/793], respectively).Conclusions These findings suggest that earlier intervention may be needed to address obesity as a disease. Most physicians and PwO recognized the importance of normal weight, but few PwO achieved weight loss targets, which may suggest an unmet need for improved weight management.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Weight loss response in patients with obesity treated with injectable semaglutide in a real-world setting
    Khaled Alabduljabbar
    Moath Alsaqaaby
    Karl J. Neff
    Michael Crotty
    Carel W. le Roux
    Endocrine, 2024, 83 : 392 - 398
  • [32] The Impact of Weight Loss during Chemoradiotherapy for Unresectable Esophageal Cancer: Real-World Results
    Huang, Tzu-Ting
    Chou, Shang-Yu
    Lin, Yun-Hsuan
    Li, Shau-Hsuan
    Chen, Yen-Hao
    Lu, Hung-, I
    Lo, Chien-Ming
    Fang, Fu-Min
    Chiu, Yi-Chun
    Chou, Yeh-Pin
    Wang, Yu-Ming
    LIFE-BASEL, 2022, 12 (05):
  • [33] Bictegravir: worth the weight? Weight gain associated with bictegravir in the real-world setting
    Soni, S.
    Davies, R.
    Clark, F.
    Underwood, J.
    HIV MEDICINE, 2020, 21 : 54 - 54
  • [34] How Effective Is Weight Loss by Oral Semaglutide on Glycemic Control in a Real-World Setting?
    Kesavadev, Jothydev
    Shankar, Arun
    Joshi, Shashank R.
    Ashik, Asha
    Yasmin, Shahana
    Basanth, Anjana
    Raj, Sourav K.
    Jothydev, Sunitha
    DIABETES, 2024, 73
  • [35] Weight loss response in patients with obesity treated with injectable semaglutide in a real-world setting
    Alabduljabbar, Khaled
    Alsaqaaby, Moath
    Neff, Karl J.
    Crotty, Michael
    le Roux, Carel W.
    ENDOCRINE, 2024, 83 (02) : 392 - 398
  • [36] Management and Outcomes of Pancreatic Cancer in French Real-World Clinical Practice
    Jooste, Valerie
    Bengrine-Lefevre, Leila
    Manfredi, Sylvain
    Quipourt, Valerie
    Grosclaude, Pascale
    Facy, Olivier
    Lepage, Come
    Ghiringhelli, Francois
    Bouvier, Anne-Marie
    CANCERS, 2022, 14 (07)
  • [37] Weight Loss Targets Realization by Patients Living with Overweight or Obesity-Real World Data
    Oieru, Dan
    Haikin, Bozhena
    Moisa, Noy
    OBESITY, 2023, 31 : 162 - 162
  • [38] Real-world evidence of characteristics and factors influencing herbal medicine use for weight loss in adults
    Lee, Boram
    Yang, Changsop
    Yim, Mi Hong
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [39] Development and applicability of modified weight loss grading system in cancer: a real-world cohort study
    Xie, Hailun
    Ruan, Guotian
    Wei, Lishuang
    Zhang, Heyang
    Ge, Yizhong
    Lin, Shiqi
    Song, Mengmeng
    Zhang, Qi
    Zhang, Xi
    Wang, Ziwen
    Liu, Chenan
    Shi, Jinyu
    Liu, Xiaoyue
    Yang, Ming
    Zheng, Xin
    Chen, Yue
    Zhang, Xiaowei
    Deng, Li
    Shi, Hanping
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2023, : 2090 - 2097
  • [40] Medications and conditions associated with weight loss in patients prescribed semaglutide based on real-world data
    Powell, William
    Song, Xing
    Mohamed, Yahia
    Walsh, Dave
    Parks, Elizabeth J.
    McMahon, Tamara M.
    Khan, Mirza
    Waitman, Lemuel R.
    OBESITY, 2023, 31 (10) : 2482 - 2492